Investigating how certain proteins contribute to age-related vision loss
Cellular and molecular mechanisms of AIM2 and NLRP3 inflammasome activation in age-related macular degeneration
This study is looking at how certain immune responses in the eye might contribute to age-related macular degeneration (AMD), with the hope of finding new ways to reduce inflammation and improve treatments for people with this condition.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts General Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11013861 on NIH RePORTER |
What this research studies
This research focuses on understanding the cellular and molecular mechanisms behind the activation of inflammasomes, specifically AIM2 and NLRP3, in age-related macular degeneration (AMD). By studying a genetic mouse model, the researchers aim to uncover how these inflammasomes contribute to the disease process and explore new therapeutic approaches that could inhibit inflammation without disrupting essential functions of the retina. The goal is to develop novel treatments that specifically target the underlying causes of AMD, potentially leading to better outcomes for patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are older adults experiencing symptoms of age-related macular degeneration, particularly those with neovascular AMD.
Not a fit: Patients with other forms of macular degeneration or those without any retinal diseases may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that improve vision and quality of life for patients suffering from age-related macular degeneration.
How similar studies have performed: Previous research has shown promise in targeting inflammasomes for other inflammatory conditions, suggesting potential for success in this novel approach to AMD.
Where this research is happening
Boston, United States
- Massachusetts General Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Marneros, Alexander Georg — Massachusetts General Hospital
- Study coordinator: Marneros, Alexander Georg
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.